Live Last read · last published · next check
➤ FDA acceptance and priority review of NDA for treatment of Stargardt disease type 1 ➤ Ocular development candidate advanced for complement-associated retinal diseases ➤ New integration to expand scleral lens selection and diagnostic flexibility ➤ Clinical results for patients with advanced retinal disease with wearable visual assistive device ➤ Company news ➤ ASCRS news and events ➤ EyeWorld…
➤ FDA clearance of surgical system for canaloplasty followed by trabeculotomy ➤ Latest clinical experience for fully robotic-assisted cataract surgery ➤ Patient enrollment complete in clinical trial evaluating investigational gene therapy for LCA5-associated inherited retinal disease ➤ Enrollment complete in pivotal Phase 3 trials for treatment of DME ➤ Positive FDA pre-IND feedback supporting…
➤ FDA approval for treatment of wet AMD ➤ Patient enrollment complete for 510(k) pivotal study for microshunt ➤ Key findings in using PROSE for NK ➤ Successful End-of-Phase 1 Type B meeting for non-atropine eye drop ➤ Digital journal invites original case report submissions ➤ Company news ➤ ASCRS news and events The post EyeWorld Weekly, July 31, 2026 appeared first on EyeWorld .
➤ Launch of preloaded IOL delivery system ➤ First U.S. patient randomized in pivotal study for intermediate to advanced dry AMD ➤ Two new offerings to boost success with presbyopia drop ➤ Company news ➤ ASCRS news and events ➤ EyeWorld article of the week The post EyeWorld Weekly, July 24, 2026 appeared first on EyeWorld .
➤ First patient enrolled in Phase 3 study of cenegermin-bkbj in NAION ➤ New AI-powered digital health platform ➤ FDA Advisory Committee meeting for discussion of low-dose atropine therapy ➤ Selection of lead clinical candidate for gene therapy for Stargardt disease ➤ ASCRS news and events ➤ EyeWorld article of the week The post EyeWorld Weekly, July 17, 2026 appeared first on EyeWorld .
➤ Launch of biosimilar for retinal disease ➤ New partnership to advance perimetry program ➤ Approval of thyroid eye disease treatment ➤ Collaboration to develop adjustable PCIOLs ➤ Progress in treatment for neuropathic corneal pain ➤ Priority review for thyroid eye disease treatment ➤ RMAT designation granted to investigational magnetic human corneal endothelial cell therapy ➤ Complimentary access…
Ophthalmology continues to strive to balance the goal of environmental sustainability with patient safety concerns. In this EyeSustain Update column, a glaucoma specialist/CEO of Drop Mate discussed the development and clinical implications of an automated ultraviolet irradiation system designed to enable safe reuse of ophthalmic devices. The post Sustainable reuse of ophthalmic devices: a novel…
The article recaps a symposium at the ASCRS Annual Meeting hosted by the combined societies of ASCRS, ESCRS, APACRS focusing on topics in AI, robotics, and surgical simulation, with representatives from all three societies presenting. The post AI, robotics, and surgical simulation: a 2026 ASCRS Annual Meeting highlight appeared first on EyeWorld .
If refractive surgeons had a motto, it probably would be to never settle. Just look at the evolution of LASIK treatment planning ecosystems and treatment refinements—traditional, wavefront-guided, wavefront-optimized, topography-guided, and ray tracing. Three experts shared their thoughts on and experiences with some of the newer LASIK planning platforms. The post The evolution of LASIK treatment…
Corneal tissues procedures are one of the approaches available to help treat corneal conditions, like keratoconus, and offer some patients an option other than transplantation. Several experts discussed these procedures, how they fit in with other options, and how they’re being utilized today. The post Expanding applications for corneal tissue procedures appeared first on EyeWorld .
